Early Insights From Clinical Trials of Typhoid Conjugate Vaccine. (29th July 2020)

• Record Type: Journal Article
• Authors: Neuzil, Kathleen M; Basnyat, Buddha; Clemens, John D; Gordon, Melita A; Patel, Priyanka D; Pollard, Andrew J; Shakya, Mila; Qadri, Firdausi
• Is Part Of: Clinical infectious diseases. Volume 71(2020)Supplement 2
• Page Start: S155
• Page End: S159
• Publication Date: 2020-07-29
• Subjects: clinical trials -- conjugate vaccine -- typhoid -- TyVAC; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciaa370
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: Clinical trials of typhoid conjugate vaccine (TCV) are ongoing in 4 countries. Early data confirm safety, tolerability, and immunogenicity of typhoid conjugate vaccine, and early efficacy results are promising. These data support World Health Organization recommendations and planned country introductions. Forthcoming trial data will continue to inform programmatic use of typhoid conjugate vaccine.